Zydus Lifesciences wins FDA final approval for Isoproterenol HCL injection

Zydus Lifesciences wins FDA final approval for Isoproterenol HCL injection

Zydus Lifesciences has secured final approval for Isoproterenol Hydrochloride (HCL) Injection USP, 0.2 mg/mL and 1 mg/5 mL (0.2 mg/mL) single-dose vials from the US Food and Drug Administration (FDA). The approved product is a generic version of Isuprel Injection. Isoproterenol hydrochloride injection has been approved for improving hemodynamic status in patients in distributive shock […]